English Korean Chinese
ホーム > 市場調査レポート > 医薬品 > ブラジルの医療市場分析
カテゴリ
医薬品 (4964)
OTC (153)
がん (943)
ドラッグデリバリー (185)
ワクチン (181)
感染症 (353)
規制環境 (132)
後発医薬品 (135)
骨疾患 (37)
処方薬 (158)
神経疾患 (174)
精神疾患 (89)
製薬企業関連 (531)
創薬 (1524)
糖尿病 (193)
動物用医薬 (17)
肥満症 (44)
市場調査レポート

ブラジルの医療市場分析

GPS Healthcare Markets Analysis in Brazil

発行 Frost & Sullivan
出版日 2008年01月 商品コード 59558
ページ情報 英文  
価格
US$ 6,000 換算 ¥ 482,820 (税抜) Web Access (Regional License)
US$ 6,500 換算 ¥ 523,055 (税抜) Hard Copy & Web Access (Regional License)


原文目次

Abstract

This study provides a comprehensive overview of the pharmaceuticals and drugs market and the Healthcare IT market. Researched country is Brazil. Included are competitive profiles, distribution network discussions, pricing analysis, drug pipelines, regulatory issues, major market drivers and restraints, market shares by revenue and commercial forecasts from 2007-2011.

Table of Contents

1 MARKET INTRODUCTION AND EXECUTIVE SUMMARY

  • Market Introduction and Executive Summary
    • Executive Summary
    • Research Scope and Methodology
    • An Overview of the Healthcare Sector

2 HEALTHCARE IT

  • Market Measurements
    • Market Engineering Measurements
    • Industry Challenges
    • Market Drivers
    • Market Restraints
  • Market Size and Forecast
    • Market Size and Forecast
  • Market Trends
    • Market Trends
    • Product Pricing Analysis
  • Competitive Structure and Market Share Analysis
    • Competitive Structure and Market Share Analysis

3 PHARMACEUTICALS AND DRUGS MARKET

  • Market Measurements
    • Market Enginnering Measurements
    • Industry Challenges
    • Market Drivers
    • Market Restraints
  • Market Size and Forecast
    • Market Size and Forecasts
  • Market Trends
    • Market Trends
  • Competitive Structure and Market Share Analysis
    • Competitive Structure and Market Share Analysis
  • Product Measurements
    • Market Trends
    • Product Pricing Analysis

4 DECISION SUPPORT DATABASE

  • Decision Support Database
    • Total Healthcare Expenditure
    • Government Healthcare Expenditure
    • Private Healthcare Expenditure
    • Hospitals
    • Percent Pharma R&D Expenditure
    • Pharma R&D Expenditure
Back to Top